Arthur Tzianabos is the founder of Homology Medicines. Homology Medicines has raised $44M in total funding. Latest round: Series A.
Arthur Tzianabos is the CEO of Homology Medicines, a genetics medicine firm based in Lexington, Massachusetts. The company is developing a proprietary gene editing technology platform to treat rare genetic disorders. Homology Medicines raised $43.5 million in Series A Preferred Stock financing.
Full founder directory · Investor directory · Company funding database · Fundraising library